Table 1. Characteristics of the patients (n=55) on entry into the trial.

Characteristic	n
Patients evaluable for response	54
Mean age; years (range)	77 (66–87)
Primary tumour
T2–T3	32
T4	23
Lymph node involvement
N0	30
N1	20
N2	5
Histology grade
GI	3
GII	24
GIII	6
Not known	22
ER status
ER+:50–60%	12
ER+:70–80%	13
ER+:90–95%	29
HER2 overexpression	8 (14.5%)
Karnofsky index
100%	34
90%	9
80%	5
70%	6

ER=oestrogen receptor.